Lausanne, Switzerland

Philipp Bucher



 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2012-2020

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Philipp Bucher

Introduction

Philipp Bucher is a notable inventor based in Lausanne, Switzerland. He has made significant contributions to the field of gene transfer and expression in mammalian cells. With a total of three patents to his name, Bucher is recognized for his innovative approaches to enhancing protein production in eukaryotic cells.

Latest Patents

Bucher’s latest patents include a groundbreaking invention titled "High efficiency gene transfer and expression in mammalian cells by a multiple transfection procedure of MAR sequences." This invention relates to purified and isolated DNA sequences that have protein production increasing activity. Specifically, it focuses on the use of matrix attachment regions (MARs) to enhance protein production in eukaryotic cells. The patent also discloses a method for identifying these active regions, particularly MAR nucleotide sequences, and the application of these characterized active MAR sequences in a new multiple transfection method.

Career Highlights

Philipp Bucher is currently associated with Selexis S.A., a company known for its advancements in cell line development and protein production technologies. His work at Selexis has positioned him as a key player in the biotechnology sector, contributing to innovative solutions that address complex challenges in gene therapy and protein engineering.

Collaborations

Bucher has collaborated with several professionals in his field, including Pierre Alain Girod and Duc-Quang Nguyen. These collaborations have fostered a dynamic exchange of ideas and expertise, further enhancing the impact of his work.

Conclusion

Philipp Bucher is a distinguished inventor whose work in gene transfer and expression has the potential to revolutionize protein production in mammalian cells. His innovative patents and collaborations reflect his commitment to advancing biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…